Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01753934 · ClinicalTrials.gov registry record

Diabetic Ketoacidosis and Its Impact on the Brain

A clinical trial of Diabetes Mellitus, sponsored by Stanford University.

Completed
Registry status
24
Enrollment target
1
Study location

NCT01753934 is a study of Diabetes Mellitus that has completed, run by Stanford University. The registered enrollment target is 24 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01753934, a study of Diabetes Mellitus, has completed, sponsored by Stanford University.

COMPLETED
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

About the Study: This research study is being conducted to see if diabetic ketoacidosis has any impact on learning, behavior and development in children with Type 1 diabetes mellitus. If there is an impact, is it transient or persistent? Sixty to 80 children between the ages of 4 to 17 years with Type 1 diabetes mellitus will have neuropsychological testing and a non-sedated MRI scan of the head performed. The investigators will compare this to a control group of 30-40 children between the ages of 4 to 17 years without Type 1 diabetes mellitus. The children with Type 1 diabetes mellitus will not have any changes made to their current diabetes regimen. The children with Type 1 diabetes mellitus should continue to check blood glucose values as required by your doctor and bring their meter(s) for downloading to each visit. The children with Type 1 diabetes mellitus should also tell your doctor about the frequency of severe low and high blood glucose values.

Conditions Studied

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2011-05
Est. Completion 2013-10

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01753934

The ClinicalTrials.gov registry entry for NCT01753934 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.

NCT01753934 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01753934 about?

NCT01753934 is a clinical study titled "Diabetic Ketoacidosis and Its Impact on the Brain". About the Study: This research study is being conducted to see if diabetic ketoacidosis has any impact on learning, behavior and development in children with Type 1 diabetes mellitus. If there is an impact, is it transient or persistent? Sixty to 80 children between the ages of 4 to 17 years with Ty...

What is the current status of trial NCT01753934?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2011-05. Estimated completion is 2013-10.

What conditions does trial NCT01753934 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

Who is sponsoring clinical trial NCT01753934?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01753934 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.